T21 (Risedronate Sodium Delayed-Release 35 mg)
Pill with imprint T21 is White, Elliptical / Oval and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Risedronate is used in the treatment of paget's disease; prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T21
Risedronate Sodium Delayed-Release
- Imprint
- T21
- Strength
- 35 mg
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- National Drug Code (NDC)
- 00093-5509
Related Images for "T21"
More about risedronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 51 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Patient Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.